Explore how the Los Angeles longevity industry is turning aging into an investable frontier through biotech, AI diagnostics, and venture capital.
Biogen (NASDAQ:BIIB) executives highlighted progress across several pipeline programs during a discussion that focused on the company’s tau antisense oligonucleotide (ASO) program in Alzheimer’s ...
Satellite imaging company Planet Labs saw its stock surge in extended trading on Thursday after delivering record financial ...
From the precision required in medical imaging to the millisecond-sensitive environments of live broadcasting and esports, ...
Government, academia, and industry have come together to help push quantum technologies from research into the real world. When most people hear the word “quantum,” they might think of either ...
Join ELRIG at the Advances in Cell-based Screening 2026 for key insights into drug discovery from top scientists.
Ovid Therapeutics (NASDAQ:OVID) outlined new pipeline and financing updates alongside its fourth-quarter and full-year 2025 results, highlighting regulatory clearance in Australia for its KCC2 direct ...
A Joint American-Israeli Achievement Perhaps no area better illustrates the strategic ROI of the U.S.-Israel partnership than missile defense technology. The multi-layered Israeli air defense ...
Recruiting and retaining an engaged and talented workforce is a major issue for most health systems. To address the issue, ...
Three presentations at ACC reinforce Heartflow’s AI-powered technology predicts MACE, drives superior lipid outcomes and results in ...
These handy tools tackle stubborn bolts, messy workspaces, cumbersome measurements, and other tricky tasks across the home, ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results